Bcl-2 Gene Therapy Prevents Aminoglycoside-Induced Degeneration of Auditory and Vestibular Hair Cells

被引：34
作者：
Pfannenstiel, Susanna C. [1 ,3 ]
Praetorius, Mark [3 ]
Plinkert, Peter K. [3 ]
Brough, Douglas E. [2 ]
Staecker, Hinrich [1 ]
机构：
[1] Univ Kansas, Dept Otolaryngol Head & Neck Surg, Sch Med, Kansas City, KS 66160 USA
[2] GenVec Inc, Gaithersburg, MD USA
[3] Univ Heidelberg, Dept Otolaryngol, Heidelberg, Germany
来源：
AUDIOLOGY AND NEURO-OTOLOGY | 2009年 / 14卷 / 04期
关键词：
Adenovector; Aminoglycosides; bcl-2 gene therapy; Gentamicin; Mice; Ototoxicity; Outer hair cells; Vestibulotoxicity; INNER-EAR; IN-VIVO; MEDIATED DELIVERY; DEATH; COCHLEAR; GENTAMICIN; OTOTOXICITY; VECTOR; EXPRESSION; MOUSE;
D O I：
10.1159/000192953
中图分类号：
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号：
100104 ; 100213 ;
摘要：
To evaluate the protective effects of bcl-2, we have developed an in vivo model of gentamicin ototoxicity in C57BL/6 mice using intratympanic delivery of gentamicin. Hair cell survival was evaluated using myosin VIIa immunohistochemistry, cytocochleogram and auditory brainstem response (ABR) testing. At 10 days after gentamicin application, a consistent loss of outer hair cells was seen. Mice were pretreated with an adenovector expressing human bcl-2 (Ad.11D.bcl-2) or a control vector (Ad.11D). Seventy-two hours after vector delivery mice were treated with intratympanic gentamicin and evaluated at 10 days after ototoxin delivery. Pretreatment with Ad. 11D. bcl-2 resulted in morphologic protection of hair cells and preservation of hearing thresholds measured by ABR. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码：254 / 266
页数：13
相关论文
共 39 条
  • [21] A modified adenovirus can transfect cochlear hair cells in vivo without compromising cochlear function
    Luebke, AE
    Steiger, JD
    Hodges, BL
    Amalfitano, A
    [J]. GENE THERAPY, 2001, 8 (10) : 789 - 794
  • [22] M40403, a superoxide dismutase mimetic, protects cochlear hair cells from gentamicin, but not cisplatin toxicity
    McFadden, SL
    Ding, DL
    Salvemini, D
    Salvi, RJ
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 186 (01) : 46 - 54
  • [23] Chinchilla models of selective cochlear hair cell loss
    McFadden, SL
    Ding, DL
    Jiang, HY
    Woo, JM
    Salvi, RJ
    [J]. HEARING RESEARCH, 2002, 174 (1-2) : 230 - 238
  • [24] Inner ear changes with intracochlear gentamicin administration in guinea pigs
    Okuda, T
    Sugahara, K
    Shimogori, H
    Yamashita, H
    [J]. LARYNGOSCOPE, 2004, 114 (04) : 694 - 697
  • [25] Analysis of gentamicin kinetics in fluids of the inner ear with round window administration
    Plontke, SKR
    Wood, AW
    Salt, AN
    [J]. OTOLOGY & NEUROTOLOGY, 2002, 23 (06) : 967 - 974
  • [26] Hearing preservation after inner ear gene therapy: The effect of vector and surgical approach
    Praetorius, M
    Baker, K
    Weich, CM
    Plinkert, PK
    Staecker, H
    [J]. ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 2003, 65 (04): : 211 - 214
  • [27] Pharmacodynamics of adenovector distribution within the inner ear tissues of the mouse
    Praetorius, Mark
    Baker, Kim
    Brough, Douglas E.
    Plinkert, Peter
    Staecker, Hinrich
    [J]. HEARING RESEARCH, 2007, 227 (1-2) : 53 - 58
  • [28] Adenoviral-mediated gene transfer into guinea pig cochlear cells in vivo
    Raphael, Y
    Frisancho, JC
    Roessler, BJ
    [J]. NEUROSCIENCE LETTERS, 1996, 207 (02) : 137 - 141
  • [29] Schacht J, 1998, OTOLARYNG HEAD NECK, V118, P674, DOI 10.1016/S0194-5998(98)70239-6
  • [30] Relationship between insult intensity and mode of hair cell loss in the vestibular system of rats exposed to 3,3′-iminodipropionitrile
    Seoane, A
    Demêmes, D
    Llorens, J
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 2001, 439 (04) : 385 - 399
1234